Bimekizumab for Hidradenitis Suppurativa
At SOMA Skin & Laser, we understand the challenges of hidradenitis suppurativa (HS)—a painful, chronic skin condition that affects quality of life. Bimekizumab is an innovative biologic treatment that offers new hope for patients struggling with moderate to severe HS.
What is Bimekizumab?
Bimekizumab is a dual IL-17A and IL-17F inhibitor, targeting two key inflammatory proteins that drive the symptoms of HS. By blocking these cytokines, Bimekizumab helps reduce inflammation, flare-ups, and lesion formation, leading to less pain, fewer abscesses, and improved skin healing.
How Bimekizumab Helps with Hidradenitis Suppurativa
- Reduces painful nodules and abscesses
- Decreases inflammation and flare-ups
- Improves wound healing and prevents scarring
- Enhances quality of life with long-term symptom control
Who is a Candidate for Bimekizumab?
Bimekizumab is designed for adults with moderate to severe HS who have not found relief with traditional treatments like antibiotics, steroids, or other biologics. If you experience persistent flare-ups, draining tunnels (sinus tracts), or significant pain, Bimekizumab may be an option for you.
What to Expect from Treatment
Bimekizumab is administered via subcutaneous injection on a scheduled basis. Many patients experience visible improvements within weeks of starting treatment. At SOMA Skin & Laser, our dermatology experts will develop a personalized treatment plan to help you achieve the best possible results.
Schedule a Consultation
If you’re living with hidradenitis suppurativa and looking for an effective, cutting-edge treatment, Bimekizumab may be right for you. Contact SOMA Skin & Laser today to discuss your options and start your journey toward clearer, healthier skin.
Call us at 973-763-7546
Visit us at our Millburn, NJ or Paramus, NJ locations.